XML 32 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
9 Months Ended
Dec. 31, 2017
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts): 
 
 
For the three months ended
 
For the nine months ended
 
 
December 31,
 
December 31,
 
 
2017
 
2016
 
2017
 
2016
Basic earnings per share:
 
 
 
 

 
 
 
 

Net earnings
 
$
22,941

 
$
1,073

 
$
18,305

 
$
12,189

 
 
 
 
 
 
 
 
 
Basic weighted-average shares outstanding
 
79,043

 
77,507

 
78,983

 
77,475


 
 

 
 

 
 

 
 

Basic earnings per share
 
$
0.29

 
$
0.01

 
$
0.23

 
$
0.16

 
 
 
 
 
 
 
 
 
Diluted earnings per share:
 
 

 
 

 
 

 
 

Basic weighted-average shares outstanding
 
79,043

 
77,507

 
78,983

 
77,475

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method
 
2,826

 
2,344

 
2,611

 
2,019

Diluted weighted-average shares outstanding
 
81,869

 
79,851

 
81,594

 
79,494


 
 

 
 

 
 

 
 

Diluted earnings per share
 
$
0.28

 
$
0.01

 
$
0.22

 
$
0.15


 
Options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings per share because the effect was anti-dilutive are shown below (shares in thousands): 
 
 
For the three months ended
 
For the nine months ended
 
 
December 31,
 
December 31,
 
 
2017
 
2016
 
2017
 
2016
Number of shares outstanding under options, warrants and restricted stock units
 
97

 
156

 
89

 
345

Range of exercise prices for options
 
$32.85

 
$32.85

 
$32.85

 
$20.27-$32.85


 
Stockholders’ Equity
 
On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded, most recently on July 28, 2016.  Under the modified common stock repurchase program, the Company may purchase up to $400.0 million of its common stock through the period ending June 30, 2018. During the nine months ended December 31, 2017, the Company repurchased 1.6 million shares of its common stock for $39.4 million.  Through December 31, 2017, the Company had repurchased a total of 18.4 million shares of its stock for $325.2 million, leaving remaining capacity of $74.8 million under the stock repurchase program.
 
Accumulated Other Comprehensive Income
 
Accumulated other comprehensive income accumulated balances of $9.8 million and $8.0 million at December 31, 2017 and March 31, 2017, respectively, reflect accumulated foreign currency translation adjustments.